Literature DB >> 818342

Parkinsonian akinesia, rigidity and tremor in the monkey. Histopathological and neuropharmacological study.

J C Péchadre, L Larochelle, L J Poirier.   

Abstract

Parkinsonian postural tremor and rigidity most likely involve the disruption of the dopaminergic (DA) nigrostriatal mechanisms and the corresponding rubro-olivo-cerebello-rubral loop without excluding the involvement of related dentato-rubral and dentato-thalamic nervous fascicles. The integrity of the magnocellular division of the red nucleus and of the rubrotegmentospinal pathway, however, is apparently essential for the expression of rigidity. Akinesia most likely results from the bilateral involvement of brain stem catecholaminergic (CA) mechanisms including the DA nigrostriatal pathways. Finally the integrity of the pallidothalamic fibers seems to represent an essential feature for the improvement of these motor disorders by DA agonists, suggesting that certain of these agents, such as apomorphine, exert their main effects through the neostriatal DA receptors.

Entities:  

Mesh:

Year:  1976        PMID: 818342     DOI: 10.1016/0022-510x(76)90100-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Parkinsonism: If surgery is necessary, can it help spontaneous movement and motor fatiguing?

Authors:  C H Meyer
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

2.  Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area.

Authors:  K Kinoshita; Y Watanabe; H Asai; M Yamamura; Y Matsuoka
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease.

Authors:  M M Lewis; G Du; S Sen; A Kawaguchi; Y Truong; S Lee; R B Mailman; X Huang
Journal:  Neuroscience       Date:  2011-01-04       Impact factor: 3.590

4.  Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects.

Authors:  Hideo Mure; Shigeki Hirano; Chris C Tang; Ioannis U Isaias; Angelo Antonini; Yilong Ma; Vijay Dhawan; David Eidelberg
Journal:  Neuroimage       Date:  2010-09-17       Impact factor: 6.556

Review 5.  The use of nonhuman primate models to understand processes in Parkinson's disease.

Authors:  Javier Blesa; Inés Trigo-Damas; Natalia López-González Del Rey; José A Obeso
Journal:  J Neural Transm (Vienna)       Date:  2017-03-29       Impact factor: 3.575

Review 6.  Alterations in forebrain catecholamine metabolism produced by cerebellar lesions in the rat.

Authors:  S R Snider; R S Snider
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

7.  Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.

Authors:  Feifei Wang; Takao Yasuhara; Tetsuro Shingo; Masahiro Kameda; Naoki Tajiri; Wen Ji Yuan; Akihiko Kondo; Tomohito Kadota; Tanefumi Baba; Judith Thomas Tayra; Yoichiro Kikuchi; Yasuyuki Miyoshi; Isao Date
Journal:  BMC Neurosci       Date:  2010-04-26       Impact factor: 3.288

8.  Akinesia in Parkinsonism. Relation between spontaneous movement (other than tremor) and voluntary movements made on command.

Authors:  C H Meyer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-07       Impact factor: 10.154

9.  Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.

Authors:  K S Rommelfanger; G L Edwards; K G Freeman; L C Liles; G W Miller; D Weinshenker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205

10.  Scoliosis in patients with Parkinson's disease.

Authors:  Jong Sam Baik; Jeong Yeon Kim; Joong Hyun Park; Sang Won Han; Jae Hyeon Park; Myung Sik Lee
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.